Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jin

Showing results (241-250 of 290) with videos related to

Pageof 29
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Study on prevalence of physical activity in rural residents in four counties (districts) of Shanxi and Chongqing]Y F Zhao, J X Ma, J H Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2002
Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' groupJ I Levin, J M Chen, M T Du, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 25, 2024
[Arterial prophylactic occlusion technique in the application of surgery for locally advanced pancreatic cancer with arterial involvement after conversion therapy]K L Zheng, X Y Liu, X H Shi, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinasesJ I Levin, Y Gu, F C Nelson, et al.
The Pharmacogenomics Journal|April 1, 2015
Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapyS Cao, S Wang, H Ma, et al.
Journal of Dental Research|June 13, 2020
Genomic Signature of Mismatch Repair Deficiency in Areca Nut-Related Oral CancerW F Yang, N Qin, X Song, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitorsA Zask, Y Gu, J D Albright, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groupsJ I Levin, J Chen, M Du, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic aminesJ I Levin, J M Chen, M T Du, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamatesJ I Levin, J M Chen, K Cheung, et al.
Pageof 29

Showing results (241-250 of 290) with videos related to

Sort By:
Pageof 29
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Study on prevalence of physical activity in rural residents in four counties (districts) of Shanxi and Chongqing]Y F Zhao, J X Ma, J H Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2002
Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' groupJ I Levin, J M Chen, M T Du, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 25, 2024
[Arterial prophylactic occlusion technique in the application of surgery for locally advanced pancreatic cancer with arterial involvement after conversion therapy]K L Zheng, X Y Liu, X H Shi, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinasesJ I Levin, Y Gu, F C Nelson, et al.
The Pharmacogenomics Journal|April 1, 2015
Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapyS Cao, S Wang, H Ma, et al.
Journal of Dental Research|June 13, 2020
Genomic Signature of Mismatch Repair Deficiency in Areca Nut-Related Oral CancerW F Yang, N Qin, X Song, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitorsA Zask, Y Gu, J D Albright, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groupsJ I Levin, J Chen, M Du, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic aminesJ I Levin, J M Chen, M T Du, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamatesJ I Levin, J M Chen, K Cheung, et al.
Pageof 29